Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Long-Term Debt

$1.99B

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Long-Term Debt

Latest reported$1.99Bperiod endingJun 30, 2026

Latest reported$1.99Bperiod endingJun 30, 2026

REGN Quarterly Long-Term Debt ($0.00 → $1.99B)

Quarterly long-term debt

High-resolution chart · PNG

REGN long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Long-Term Debt — Quarterly (USD)
Period ending	Long-Term Debt (USD)
Jun 30, 2001	1,749,000
Mar 31, 2001	1,914,000
Dec 31, 2000	2,069,000
Sep 30, 2000	2,177,000
Jun 30, 2000	2,336,000
Mar 31, 2000	2,520,000
Dec 31, 1999	2,700,000
Sep 30, 1999	2,100,000
Jun 30, 1999	2,500,000
Mar 31, 1999	2,800,000
Dec 31, 1998	3,100,000
Sep 30, 1998	2,700,000
Jun 30, 1998	3,600,000
Mar 31, 1998	3,500,000
Dec 31, 1997	3,800,000
Sep 30, 1997	4,100,000
Jun 30, 1997	4,200,000
Mar 31, 1997	4,400,000
Dec 31, 1996	5,100,000
Sep 30, 1996	5,200,000
Jun 30, 1996	4,900,000
Mar 31, 1996	4,900,000
Dec 31, 1995	6,000,000
Sep 30, 1995	7,000,000
Jun 30, 1995	7,700,000
Mar 31, 1995	8,600,000
Dec 31, 1994	9,200,000
Sep 30, 1994	8,000,000
Jun 30, 1994	7,200,000
Mar 31, 1994	8,100,000
Dec 31, 1993	5,900,000
Sep 30, 1993	6,200,000
Jun 30, 1993	6,300,000
Mar 31, 1993	6,300,000
Dec 31, 1992	5,800,000
Sep 30, 1992	5,200,000
Jun 30, 1992	4,800,000
Mar 31, 1992	4,100,000
Dec 31, 1991	2,400,000
Sep 30, 1991	700,000
Jun 30, 1991	300,000
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.